Literature DB >> 7545097

Defective functional response to membrane stimuli in lymphocytes from patients with benign prostatic hyperplasia.

M Pérez-Blas1, B Martínez-Martín, J Carballido, J Hontoria, L I Salazar, C Olivier, M Alvarez-Mon.   

Abstract

Benign prostatic hyperplasia (BPH) is a local disturbance in the prostate that may involve an inflammatory infiltrate predominantly composed of activated lymphocytes and macrophages. The activation and proliferative response of T lymphocytes to different mitogenic signals has been analysed in peripheral blood mononuclear cells (PBMC) from 45 patients with BPH and 55 healthy controls. The PBMC obtained from the patients showed a significant specific impairment in proliferation, CD25 expression and IL-2 production in response to stimulation with lectins (phytohaemagglutinin (PHA), concanavalin A (Con A)), that was not corrected by the addition of IL-2 or of phorbol esters (phorbol myristate acetate (PMA)). Also, the CD28 response was defective in patient PBMC. Activation with anti-CD3 or anti-CD2 MoAbs was normal, but the addition of PMA to these stimuli provoked a significant defective response. Only the use of transmembrane stimuli (PMA and ionomycin) elicited responses similar to those found in the control group. The results indicate that peripheral T lymphocytes from BPH patients show a functional impairment that is mainly explained by an alteration of membrane signals (PHA, CD28) and is distal to protein kinase C (PKC) activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545097      PMCID: PMC1553224          DOI: 10.1111/j.1365-2249.1995.tb03144.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.

Authors:  R Gerli; A Bertotto; E Agea; L Lanfrancone; C Cernetti; F Spinozzi; P Rambotti
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 2.  Role of the CD28 receptor in T-cell activation.

Authors:  C H June; J A Ledbetter; P S Linsley; C B Thompson
Journal:  Immunol Today       Date:  1990-06

3.  The sheep erythrocyte receptor and both alpha and beta chains of the human T-lymphocyte antigen receptor bind the mitogenic lectin (phytohaemagglutinin) from Phaseolus vulgaris.

Authors:  G Leca; L Boumsell; M Fabbi; E L Reinherz; J M Kanellopoulos
Journal:  Scand J Immunol       Date:  1986-05       Impact factor: 3.487

4.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

5.  T-cell response to phorbol ester PMA and calcium ionophore A23187 in Down's syndrome.

Authors:  A Bertotto; S Crupi; C Arcangeli; R Gerli; F Scalise; G Fabietti; E Agea; R Vaccaro
Journal:  Scand J Immunol       Date:  1989-11       Impact factor: 3.487

Review 6.  Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.

Authors:  A Moretta; E Ciccone; G Pantaleo; G Tambussi; C Bottino; G Melioli; M C Mingari; L Moretta
Journal:  Immunol Rev       Date:  1989-10       Impact factor: 12.988

7.  Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia.

Authors:  H Mori; M Maki; K Oishi; M Jaye; K Igarashi; O Yoshida; M Hatanaka
Journal:  Prostate       Date:  1990       Impact factor: 4.104

8.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

9.  Functional defect of T cells in autoimmune gastritis.

Authors:  J A Vargas; M Alvarez-Mon; L Manzano; A Albillos; A Fernandez-Corugedo; F Albarrán; A Durántez
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  Partial deletions of the cytoplasmic domain of CD2 result in a partial defect in signal transduction.

Authors:  B E Bierer; R E Bogart; S J Burakoff
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

View more
  1 in total

1.  Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Authors:  Kouji Izumi; Lei Li; Chawnshang Chang
Journal:  Clin Investig (Lond)       Date:  2014-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.